EP
Eversept Partners’s Fate Therapeutics FATE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-43,562
| Closed | -$440K | – | 64 |
|
|
2022
Q4 | $440K | Sell |
43,562
-97,996
| -69% | -$989K | 0.04% | 55 |
|
|
2022
Q3 | $3.17M | Sell |
141,558
-585,028
| -81% | -$13.1M | 0.28% | 38 |
|
|
2022
Q2 | $18M | Buy |
726,586
+270,527
| +59% | +$6.7M | 1.28% | 19 |
|
|
2022
Q1 | $17.7M | Buy |
456,059
+201,269
| +79% | +$7.8M | 1.36% | 19 |
|
|
2021
Q4 | $14.9M | Sell |
254,790
-6,105
| -2% | -$357K | 0.95% | 22 |
|
|
2021
Q3 | $15.5M | Sell |
260,895
-85,452
| -25% | -$5.06M | 1.07% | 23 |
|
|
2021
Q2 | $30.1M | Buy |
346,347
+24,587
| +8% | +$2.13M | 2% | 14 |
|
|
2021
Q1 | $26.5M | Sell |
321,760
-77,739
| -19% | -$6.41M | 1.99% | 18 |
|
|
2020
Q4 | $36.3M | Sell |
399,499
-135,537
| -25% | -$12.3M | 4.26% | 7 |
|
|
2020
Q3 | $21.4M | Buy |
535,036
+3,778
| +0.7% | +$151K | 4.75% | 7 |
|
|
2020
Q2 | $18.2M | Buy |
531,258
+225,773
| +74% | +$7.75M | 2.5% | 13 |
|
|
2020
Q1 | $6.78M | Sell |
305,485
-55,171
| -15% | -$1.23M | 1.69% | 16 |
|
|
2019
Q4 | $7.06M | Buy |
360,656
+220,000
| +156% | +$4.31M | 1.25% | 20 |
|
|
2019
Q3 | $2.18M | Sell |
140,656
-77,200
| -35% | -$1.2M | 0.68% | 31 |
|
|
2019
Q2 | $4.42M | Sell |
217,856
-132,155
| -38% | -$2.68M | 1.24% | 21 |
|
|
2019
Q1 | $6.15M | Buy |
350,011
+185,011
| +112% | +$3.25M | 1.79% | 15 |
|
|
2018
Q4 | $2.12M | Buy |
+165,000
| New | +$2.12M | 1.15% | 19 |
|